GRAIL Inc GRAL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Grail Shares Gain as FDA Panel Votes to Support Cancer Detection Test
-
Grail's Multi-Cancer Blood Test Gets FDA Committee Vote for Premarket Approval
-
FDA Advisory Committee Votes In Favor of Approval of GRAIL's Galleri® Multi-Cancer Early Detection Test
-
This test screens for 50 cancers - but whether Medicare and other health insurers will cover it hinges on FDA approval
-
Grail Trading Halted Ahead of FDA AdCom Meeting on Galleri Blood Test
-
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference
-
GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
Trading Information
- Previous Close Price
- $132.56
- Day Range
- $134.45–143.50
- 52-Week Range
- $0.00–151.46
- Bid/Ask
- $141.00 / $143.80
- Shares Outstanding
- 44.67M
- Market Cap
- $6.40B
- Volume/Avg
- 874,339 / 873,628
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 32.22
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 910
- Website
- https://www.grail.com
Valuation
|
Metric
|
GRAL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.33 |
Price/Sales | 32.22 |
Price/Cash Flow | — |
Price/Earnings
GRAL
Financial Strength
|
Metric
|
GRAL
|
|---|---|
Quick Ratio | 10.55 |
Current Ratio | 10.95 |
Interest Coverage | — |
Quick Ratio
GRAL
Profitability
|
Metric
|
GRAL
|
|---|---|
Return on Assets (Normalized) | −10.79% |
Return on Equity (Normalized) | −12.30% |
Return on Invested Capital (Normalized) | −12.85% |
Return on Assets
GRAL
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|YBD&M#YL | LOCK|>$ | $241B | |||
| Danaher Corp
DHR
| LOCK|#PBq%Xxr | LOCK|b>% | $149B | |||
| Agilent Technologies Inc
A
| LOCK|L<h%S?S | LOCK|Wp? | $47B | |||
| IQVIA Holdings Inc
IQV
| LOCK|<bMRf%# | LOCK|#?#q# | $43B | |||
| Waters Corp
WAT
| LOCK|V?$zN<! | LOCK|S& | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|YG^<ZdW? | LOCK|<!L | $41B | |||
| Illumina Inc
ILMN
| LOCK|!<TkTBt | LOCK|YW^$ | $40B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|wK>FxNq | LOCK|<rCbk | $30B | |||
| Quest Diagnostics Inc
DGX
| LOCK|l%FWG!Y | LOCK|r%VbV | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|?tb!Ywy | LOCK|<&LB | $25B |
United States